Epigenetic effects of carcinogens

Journal of Biological Sciences

Volumn 10, Issue 3, 2010, Pages 200-208

  Gohar, Ali Vaziri ^a   Mohammadi, Abbas ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer prevention; Cancer stem cell; Drinking water; Epigenetic effects; Heavy metal

Indexed keywords

ALUMINUM; ARSENIC; CHROMIUM; DRINKING WATER; NICKEL; REACTIVE OXYGEN METABOLITE; SELENIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CHEMICAL ANALYSIS; COMPARATIVE STUDY; DNA POLYMORPHISM; EPIGENETICS; HUMAN; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION; TUMOR GENE;

EID: 77954288762     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2010.200.208     Document Type: Article

References (83)

1. Abbracchio, M.P., J.D. Heck and M. Costa, 1982. The phagocytosis and transforming activity of crystalline metal sulfide particles are related to their negative surface charge. Carcinogenesis, 3: 175-180.
2. Adams, T.K., N. Saydam, F. Steiner, W. Schaffner and J.H. Freedman, 2002. Activation of gene expression by metal-responsive signal transduction pathways. Environ. Health Perspect, 110: 813-817.
3. Alexander, J. and J. Aaseth, 1995. Uptake of chromate in human red blood cells and isolated rat liver cells: The role of the anion carrier. Analyst, 120: 931-933.
4. Alkahtani, S., 2009. Antioxidation and hypomethylation effects on genotoxicity and programmed cell death induced in mice somatic cells by arsenic trioxide. J. Biol. Sci.,9: 721-729.
5. Asadikaram, G., M. Mirzai, N. Naimi andR. Dargahi, 2008. Removal of arsenic using Acetobacter xylinum cellulose. J. Biol. Sci., 8: 209-212.
6. Bachleitner-Hofmann, T., M. Kees andH. Gisslinger, 2002. Arsenic trioxide: Acute promyelocytic leukemia and beyond. Leuk. Lymphoma, 43: 1535-1540.
7. Blankenship, L.J., F.C. Manning, J.M. Orenstein and S.R. Patierno, 1994. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol., 126: 75-83.
8. Bower, J., S. Leonard and X. Shi, 2005. Conference overview: Molecular mechanisms of metal toxicity and carcinogenesis. Mol. Cell Biochem., 279: 3-15.
9. Broday, L., W. Peng, M.H. Kuo, K. Salnikow and M. Zoroddu et al., 2000. Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res., 60: 238-241.
10. Cangul, H., L. Broday, K. Salnikow, J. Sutherland and W. Pengx, et al2002. Molecular mechanisms of nickel carcinogenesis. Toxicol. Lett., 127: 69-75.
11. Carlisle, D.L., D.E. Pntchard, J. Singh, B.M. Owens and L.J. Blankenship, J.M. Orenstei and S.R. Patierno, 2000. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium(VI): Effect of ascorbate and tocopherol. Toxicol. Sci., 55: 60-68.
12. Ceryak, S., C. Zingariello, T. O'Brien and S.R. Patierno, 2004. Induction of pro-apoptotic and cell cycle-inhbiting gene in chromium (Vl)-treated human lung fibroblasts: Lack of effect of ERK. Mol. Cell Biochem., 255: 139-149.
13. Chen, T. and Y.S. Wong, 2008. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Int. J. Biochem. Cell Biol., 41: 666-616.
14. Cowell, J.K., 2001. Molecular Genetics of Cancer. 2nd Edn., BIOS Scientific Publishers Ltd., Oxford, UK.
15. Darbre, P.D., 2005. Aluminium, antiperspirants and breast cancer. J. Inorganic Biochem., 99: 1912-1919.
16. Ding, W., L.G. Hudso, X. Sun, C. Feng andK.J. Liu, 2008. As(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes. Free Radiat. Biol. Med., 45: 1065-1072.
17. Drukteinis, J.S., T. Medrano, E.A. Ablordeppey, J.M. Kitzman and K. T. Shivenck, 2005. Benzo[a]pyrene, but Not 2,3,7,8-TCDD, Induces G2/M Cell Cycle Arrest p21CIPl and p53 Phosphorylation in human choriocarcinoma JEG-3 Cells: A distinct signaling pathway. Placenta, 26: S87-S95.
18. Dunnick, J.K., M.R. Elwell, A.E. Radovsky, J.M. Benson andF.F. Halm et al, 1995. Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res., 55: 5251-5256.
19. Egger, G., G. Liang, A. Aparicio and P.A. Jones, 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429: 457-463.
20. Evans, J., 2008. Antioxidant supplements to prevent or slow down the progression of AMD: A systematic review and meta-analysis. Eye, 22: 751-760.
21. Fujihara, J., Y. Fujii and T. Agusa, T. Kunito, T. Yasuda, T. Montani and H. Takeshita, 2009. Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene. Toxicol. Applied Pharmacol., 234: 41-46.
22. Galanis, A., A. Karapetsas andR. Sandaltzopoulos, 2008. Metal induced carcinogenesis, oxidative stress and hypoxia signaling. Mutat. Res. Genet. Toxicol. Environ. Mutagenesis, 674: 31-35.
23. Galans, D., V. Skiada and A. Barbouti, 2008. Redox signaling and cancer: The role of labile iron. Cancer Lett, 266: 21-29.
24. Gao, N, B.H. Jiang, S.S. Leonard, L. Corum and Z. Zhang et al, 2002. p38 signaling-mediated hypoxia-inducible factor 1α and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem., 277: 45041-45048.
25. Gao, N, L. Shen, Z. Zhang, S.S. Leonard andH. He et al, 2004. Arsenite induces HIF-lá and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol. Cell Biochem., 255: 33-45.
26. Gordan, J.D., P. Lai, V.R. Dondeti, R. Letrero and K.N. Parekh et al, 2008. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell, 14: 435-446.
27. Guttridge, D.C., C. Albanese, J.Y. Reuther, R.G. Pestell and A.S. Baldwin Jr., 1999. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclinDl. Mol. CellBiol., 19: 5785-5799.
28. Ha, L., S. Ceryak and S.R. Patierno, 2003. Chromium (VI) activates ATM: Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem., 278: 17885-17894.
29. Harley, C.B., 2008. Telomerase and cancer therapeutics. Nat. Rev. Cancer, 8: 167-179.
30. Huang, S., 2002. Histone methyltransferases, diet nutrients and tumour suppressors. Nat. Rev. Cancer, 2: 469-476.
31. Hurst R-M. Elliott A.J. Goldson and S.J. Fairweather-Tait 2008. Se-methylselenocysteine alters collagen gene and protein expression in human prostate cells. Cancer Lett., 269: 117-126.
32. Hussain, S.P., L.J. Hofseth and C.C. Harris, 2003. Radical causes of cancer. Nat. Rev. Cancer, 3: 276-285.
33. IARC, 1989. Monograph on Chromium, Nickel and Welding. I ARC, Lyon, France.
34. Imamura, T., H. Kikuchi, M.T. Herraiz, D.Y. Park and Y. Mizukami et al, 2009. HIF-1 alpha and HTF-2alpha have divergent roles in colon cancer. Int. J. Cancer, 124: 763-771.
35. Jackson, J.P., A.M. Lindroth, X. Cao and S.E. Jacobsen, 2002. Control of CpNpG DNA methylafion by the kryptonite histone H3 methyltransferase. Nature, 416: 556-560.
36. Jensen, T.J., R.J. Wozmak, K.E. Eblin, S.M. Wnek, A.J. Gandolfi and B.W. Futscher, 2009. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol. Applied Pharmacol, 235: 39-46.
37. Jones, P.A. and S.B. Baylin, 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3: 415-428.
38. Karavoltsos, S., A. Sakellari, N. Mihopoulos, M. Dassenakis andMJ. Scoullos, 2008. Evaluation of the quality of drinking-water in regions of Greece. Desalination, 224: 317-329.
39. Kasprzak, K.S. and G.S. Buzard, 2000. The Role of Metals in Oxidative Damage and Redox Cell-Signaling Derangements. In: Molecular Biology and Toxicology of Metals, Zalups, R.K. and J. Koropatnick, (Eds.). Taylor and Francis, London, pp: 477-527.
40. Ke, Q., T.P. Ellen and M. Costa, 2008. Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activity. Toxicol Applied Pharmacol, 228: 190-199.
41. Kinzler, K.W. and B. Vogelstein, 1997. Cancer-susceptibility genes: Gatekeepers and caretakers. Nature, 386: 761-763.
42. Laden, K. and CB. Felger, 1988. Antiperspirants and Deodorants. Marcel Dekker, New York.
43. Leader, J.E., C. Wang, M. Fu and R.G. Pestell, 2006. Epigenetic regulation of nuclear steroid receptors. Biochem. Pharmacol., 72: 1589-1596.
44. Lee, Y., L. Broday andM. Costa, 1998. Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels. Mutat. Res., 415: 213-218.
45. Leivadara, S.V., A.D. Nikolaou and T.D. Lekkas, 2008. Determination of organic compounds in bottled waters. Food Chem., 108: 277-286.
46. Li, R., Y. Y. Shugart, W. Zhou, Y. An and Y. Yang et al., 2009. Common genetic variations of the cytochrome P450 1A1 gene and risk of hepatocellular carcinoma in a Chinese population. Eur. J. Cancer, 45: 1239-1247.
47. Lukusa, T. and J.P. Fryns, 2008. Human chromosome fragility. Biochim. Biophys. Acta, 1779: 3-16.
48. Majumder, S., H. Kutay, J. Datta, D. Summers, S.T. Jacob and K. Ghoshal, 2006. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. J. Cell. Biochem., 97: 1300-1316.
49. Melnikova, V.O. and H.N. Ananthaswamy, 2005. Cellular and molecular events leading to the development of skin cancer. Mutat. Res. Fundam. Mol. Mechanisms Mutagenesis, 571: 91-106.
50. Mohammadi, A., A. Vaziri Gohar and M.R. Shakibaie, 2008. Mutations in tumor suppressor TP53 gene in formalin- fixed, paraffin embedded tissues of squamous cell carcinoma (SCC) of lung cancer. Am. J. Biochem. Biotehcnol., 4: 1-6.
51. Monsef, N, L. Helczynski, A. Lundwall, S. Pahlman and A. Bjartell, 2007. Localization of immunoreactive HIF-1 alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands. Prostate, 67: 1219-1229.
52. Nebert, D.W., A.L. Roe, M.Z. Dieter, W.A. Sohs, Y. Yang and T.P. Dalton, 2000. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control and apoptosis. Biochem. Pharmacol., 59: 65-85.
53. Nielsen, G.D., U. Søderberg, P.J. Jørgensen, D.M. Templeton, S.N. Rasmussen, K.E. Andersen and P. Grandjean, 1999. Absorption and retention of nickel from drinking-water in relation to food intake and nickel sensitivity. Toxicol. Applied Pharmacol., 154: 67-75.
54. Patterson, T.J., M. Ngo, P.A. Aronov, T.V. Reznikova, P.G. Green andRH. Rice, 2003. Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes. Chem. Res. Toxicol, 16: 1624-1631.
55. Ravanat, J.L., T. Douki and J. Cadet, 2001. Direct and indirect effects of UV radiation on DNA and its components. J. Photochem. Photobiol. Biol, 63: 88-102.
56. Rayman, M.P., 2000. The importance of selenium to human health. Lancet, 356: 233-241.
57. Rossman, T.G., A.N. Uddin, F.J. Burns andM.C. Bosland, 2001. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: An animal model for arsenic carcinogenesis. Toxicol. Applied Pharmacol, 176: 64-71.
58. Rossman, T.G., A.N. Uddin and F.J. Burns, 2002. Arsenite cocarcinogenesis: An animal model derived from genetic toxicology studies. Environ. Health. Perspect, 110: 749-752.
59. Sarafanov, A.G., T.I. Todorov, A. Kajdacsy-Balla, M.A. Gray, V. Macias and J.A. Centeno, 2008. Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J. Trace Element Med. Biol, 22: 305-314.
60. Satoh, E., I. Yasuda, T. Yamada Y. Suzuki and T. Ohyashiki, 2007. Involvement of NO generation in aluminum-induced cell death. Biol. Pharm. Bull., 30: 1390-1394.
61. Schnekenburger, M., L. Peng and A. Puga, 2007. HDAC1 bound to the Cyplal promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim. Biophys. Acta Gene Struct. Expression, 1769: 569-578.
62. Sell, S., 2004. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol. Hematol., 51: 1-28.
63. Stellman, S.D., M.V. Djordjevic, J.A. Britton, J.E. Muscat and M.L. Citron et al., 2000. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol. Biomarks Prev., 9: 1241-1249.
64. Sun, X., J.M. Fontaine, I. Bartl, B. Behnam, M.J. Welsh and R. Benndorf, 2007. Induction of Hsp22 (HspB8) by estrogen and the metalloestrogen cadmium in estrogen receptor-positive breast cancer cells. Cell Stress Chaperones, 2: 307-319.
65. Suzuki, K.T., A. Katagiri, Y. Sakuma, Y. Ogra and M. Ohmichi, 2004. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Toxicol. Applied Pharmacol., 198: 336-344.
66. Tamaru, H. and E.U. Selker, 2001. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature, 414: 277-283.
67. Thomas, G., 1992. MAP kinase by any other name smells just as sweet. Cell, 68: 3-6.
68. Vahter, M., 2000. Genetic polymorphism in the biotransformation of inorganic and its role in toxicity. Toxicol. Lett, 112-113: 209-217.
69. Vahter, M., 2002. Mechanisms of arsenic biotransformation. Toxicology, 181-182: 211-217.
70. Vaziri Gohar, A., A. Mohammadi and M. Heidari, 2007. Molecular Genetics of Cancer. Samer Publication, Tehran, Iran.
71. Vaziri Gohar, A. and A. Mohammadi, 2009. A simple method for DNA extraction from formalin-fixed Paraffin embedded tissue blocks. Protocol Online.
72. Vogelstein, B. andK.W. Kinzler, 2004. Cancer genes and the pathways they control. Nat. Med., 10: 789-799.
73. WHO., 2003. Arsenic in Drinking-water. Background document for development of WHO Guidelines for Drinking-water Quality. http://www.who.int/mediacentre/factsheets/fs210/en/.
74. WHO., 2005. Nickel in Drinking-Water, 2005. Background document for development of WHO guidelines for drinking-water quality. http://www.who.int/water_sanitation_health/gdwqrevision/nickel2005.pdf.
75. Wei, Y.D., K. Tepperman, M.Y. Huang, M.A. Sartor and A. Puga, 2004. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J. Biol. Chem., 279: 4110-4119.
76. Wu, J.P., L.W. Chang, H.T. Yao, H. Chang and H.T. Tsai et al., 2008. Involvement of oxidative stress and activation of aryl hydrocarbon receptor in elevation of CYP1 Al expression and activity in lung cells and tissues by arsenic: An in vitro and in vivo study. Toxicol. Sci., 107: 385-393.
77. Xiang,N., R. Zhao, G. Song and W. Zhong, 2008. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. Carcinogenesis, 29: 2175-2181.
78. Yu, M.W., IS. Horng, K.H. Hsu, Y.C. Chiang, Y.F. Liaw and C.J. Chen, 1999. Plasma selenium levels and the risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am. J. Epidemiol., 150: 367-374.
79. Zhang, Q., T. Kluz, K. Salmkow and M. Costa, 2002a. Comparison of the cytotoxicity, cellular uptake and DNA-protein crosslinks induced by potassium chromate in lymphoblast cell lines derived from three individuals. Biol. Trace Element Res., 86: 11-22.
80. Zhang, R.Y., Y. Lui, D.W. Pang, R.X. Cai and Y.P. Qi, 2002b. Spectroscopic and voltammetric study on the binding of aluminium (III) to DNA. Anal. Sci., 18: 761-766.
81. Zhang, M. and J.M. Rosen, 2006. Stem cells in the etiology and treatment of cancer. Curr. Opin. Genet. Dev., 16: 60-64.
82. Zhitkovich, A., V. Voitkun and M. Costa, 1995. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis, 16: 907-913.
83. Zou, Y., P. Niu, J. Yang, J. Yuan, T. Wu and X. Chen, 2008. The JNK signaling pathway is involved in sodium-selenite-induced apoptosis mediated by reactive oxygen in HepG2 cells. Cancer Biol. Ther., 7: 689-696.